Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Advanced Thyroid Cancer
NCT00510640Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Aug 2007
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in thyroid cancer, sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Aug 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT00510640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510640.